Vikas Shreekrishna Shirsath is an Entrepreneurial, Scientific, and Passionate leader with 22 years of experience in delivering superior business results in Drug Discovery Innovation and Development space. He is a Medicinal chemist by training and has Drug Discovery contributions in Biotech as well as CRO environment in India. He has made significant contributions to science, operations, and business during his tenure in industry. He specialises in Lead discovery, early pre-clinical development, Route scouting, Process development, IND and intellectual property.

He has over 25 International publications and more than 110 granted national phase patents, numerous strategic data disclosures and scientific publications to his credit. One of his inventions, SUVN-502 (also known as Masupirdine) has recently entered Phase-III clinical trials for mild to moderate cognition disorders and Alzheimer’s.